相关实验视频

Updated: May 10, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K

通过高通量虚拟查发现新型PTP1B抑制剂

Abhijit Debnath1, Anjna Rani1, Rupa Mazumder1

  • 1Noida Institute of Engineering and Technology [Pharmacy Institute], 19 Knowledge Park-II, Institutional Area, Greater Noida, Uttar Pradesh, India.

Current computer-aided drug design
|October 16, 2024
PubMed
概括

这项研究确定了两种新型化合物,有效抑制蛋白铁酸酶1B (PTP1B),为2型糖尿病 (T2DM) 提供了有前途的新治疗策略. 这些抑制剂表现出强烈的结合亲和力,有利的类似药物的特性,以及潜在的治疗用途的稳定性.

关键词:
这就是PTP1B.这是一种PTP1B抑制剂.这就是T2DM药物.蛋白质氨酸酸酶是一种蛋白质氨酸酸酶.2型糖尿病是什么?

更多相关视频

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.1K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

233

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...